SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: doxorubicin hydrochloride|DRUG: semaxanib|PROCEDURE: conventional surgery|RADIATION: radiation therapy|DRUG: tamoxifen
Sponsor: Case Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)